Your institution may have access to this item. Find your institution then sign in to continue.
Title
MARKETPLACE.
Abstract
The article offers information on various developments in drugs and therapeutics. Topics include the drug approvals including Cotellic (cohimetinib), for use in of patients with unresectable or metastatic melanoma and Ibrance (palbociclib), for use in combination with letrozole for the treatment of postmenopausal women with advanced stage of breast cancer. Also presented is the new drug indication including Opdivo for use in locally advanced or metastatic non-small cell lung cancer.